Skip to main content

rheumatology and immunology Archives

Autoimmunity advance

Aug. 24, 2021—Vanderbilt researchers have developed a high-throughput screening method to identify and characterize antigen-specific B cells — potential biomarkers for autoimmune disease and targets for new treatments.

Read more


New Vanderbilt Health Hendersonville expands services in Sumner County

Mar. 30, 2021—Vanderbilt University Medical Center has opened Vanderbilt Health Hendersonville, a new 31,000-square-foot facility that offers adult outpatient specialty care, along with pediatric specialty care and imaging services to the citizens of Sumner and surrounding counties.

Read more


Microbial RNA and rheumatoid arthritis

Jan. 11, 2021—Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases.

Read more


New therapeutic target for lung cancer

Nov. 12, 2020—Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.

Read more


A “torque” for tumor blood vessels

Aug. 20, 2020—Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.

Read more


Rheumatology’s Fuchs remembered for dedication to medicine, family

Oct. 30, 2019—Howard Fuchs, MD, professor of Medicine, Division of Rheumatology and Immunology, died unexpectedly Oct. 28. He was 64.

Read more


Brumbelow’s calm nature helps keep busy clinic rolling

Apr. 6, 2017—Taylor Brumbelow has a gift for quickly putting people at ease.

Read more


Pathways to delirium in the ICU

Apr. 17, 2012—Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more